Source:http://linkedlifedata.com/resource/pubmed/id/19078924
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-16
|
pubmed:abstractText |
Understanding and identifying molecular biology and genetics of endometrial cancer are central to the development of novel therapies. This article reviews the molecular basis for genesis of endometrial cancer with regard to pathogenesis, classification, and implications for targeted therapies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1526-2359
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8-13
|
pubmed:meshHeading |
pubmed-meshheading:19078924-Animals,
pubmed-meshheading:19078924-Antineoplastic Agents,
pubmed-meshheading:19078924-Clinical Trials as Topic,
pubmed-meshheading:19078924-Drug Delivery Systems,
pubmed-meshheading:19078924-Endometrial Neoplasms,
pubmed-meshheading:19078924-Female,
pubmed-meshheading:19078924-Humans
|
pubmed:year |
2009
|
pubmed:articleTitle |
The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies.
|
pubmed:affiliation |
Gynecologic Oncology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
|
pubmed:publicationType |
Journal Article,
Review
|